Cimzia® Approved In United States For Crohn’s Disease
May 15th 2008Drug InformationCrohn
According to a press release from UCB on April 22, 2008, a newpegylatedanti-TNFα, will be made available in the United States under thename Cimzia® in the next few days. This will be a new,promising option for patients suffering from moderate to severe Crohn’sDisease. Crohn’sDisease (CD) is a gastrointestinal disorder which is indicated bychronicinflammation of the wall of the digestive tract, usually in the ileumor large intestines.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
